Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease

Michelle T Lee1,2, Dhruv Mahtta1,2,3, Mahboob Alam3

  • 1Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX, USA.

Insights

Premature atherosclerotic cardiovascular disease (ASCVD) affects younger individuals, presenting unique challenges. Early identification and management of traditional and non-traditional risk factors are crucial for preventing disability and reducing healthcare costs.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Preventive Cardiology

Background:

  • Atherosclerotic cardiovascular disease (ASCVD) is a leading global cause of mortality.
  • While overall ASCVD mortality has decreased, younger populations have not seen similar improvements.
  • Premature ASCVD poses a significant and growing challenge in healthcare.

Purpose of the Study:

  • To review the literature on premature ASCVD.
  • To identify and analyze risk factors specific to younger patients with ASCVD.
  • To provide clinical insights for managing this demographic.

Main Methods:

  • Literature search for studies on premature ASCVD.
  • Definition of premature ASCVD: ischemic heart disease (IHD), ischemic cerebrovascular disease (ICVD), or peripheral arterial disease (PAD) in men ≤55 years and women ≤65 years.
  • Synthesis of findings on risk factors and management strategies.

Main Results:

  • Premature ASCVD patients frequently exhibit multiple traditional cardiovascular risk factors.
  • Genetic predispositions and non-traditional factors like substance abuse and chronic inflammation are also implicated.
  • Effective identification and management of at-risk younger individuals remain challenging for clinicians.

Conclusions:

  • Aggressive control of traditional risk factors is essential in younger ASCVD patients.
  • Optimization of primary and secondary prevention strategies is critical.
  • Lifestyle modifications are imperative to reduce disability and costs associated with premature atherosclerosis.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
264
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
475
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
579
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
146
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
121